Addressing large, unmet global markets with innovative proprietary products More »
Capitalizing on high-value, emerging markets for pharmaceutical and diagnostic products More »
Identifying early-stage companies with potential to increase value for shareholders More »
OPKO continues to make progress with its program to build a company capable of long-term growth and increasing value to its investors.
OPKO Announces 4Kscore(R) Abstracts at the 2015 American Urological Association (AUA) Annual Meeting more »
OPKO Announces Publication of Study Using Kallikrein Biomarkers of the 4Kscore(R) Test in a Large Community-Based Referral Cohort more »
OPKO Announces First Quarter Operating and Financial Results more »
OPKO Health is an opportunistic research and development company that targets large, high-growth markets.